Protein C inhibitor-A novel antimicrobial agent

PLoS Pathogens

Volumn 5, Issue 12, 2009, Pages

  Malmström, Erik ^a   Mörgelin, Matthias ^a   Malmsten, Martin ^b   Johansson, Linda ^c   Norrby Teglund, Anna ^c   Shannon, Oonagh ^a   Schmidtchen, Artur ^a   Meijers, Joost C M ^d   Herwald, Heiko ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PLASMINOGEN ACTIVATOR INHIBITOR 3; SERYLGLUTAMYLLYSYLTHREONYLLEUCYLARGINYLLYSYLTRYPTOPHANYLLEUCYLLYSINE METHIONYLPHENYLALANYLLYSYLLYSYLARGINYLGLUTAMINYLLEUCYLGLUTAMYLLEUCYLTYROSINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LIPOSOME;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BINDING SITE; BIOPSY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; EUKARYOTIC CELL; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID MEMBRANE; MEMBRANE DAMAGE; MICROBIAL GROWTH; NECROTIZING FASCIITIS; NONHUMAN; STAINING; STREPTOCOCCUS PYOGENES; THROMBOCYTE ACTIVATION; CELL MEMBRANE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; STREPTOCOCCUS PYOGENES;

ANTI-INFECTIVE AGENTS; BINDING SITES; BLOOD PLATELETS; CELL MEMBRANE; ESCHERICHIA COLI; HUMANS; IMMUNITY, INNATE; LIPOSOMES; PLATELET ACTIVATION; PROTEIN C INHIBITOR; STREPTOCOCCUS PYOGENES;

EID: 74549135127     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000698     Document Type: Article

References (37)

1. Areschoug T, Gordon S (2008) Pattern recognition receptors and their role in innate immunity: focus on microbial protein ligands. Contrib Microbiol 15: 45-60.
2. Beutler BA (2009) TLRs and innate immunity. Blood 113: 1399-1407.
3. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, et al. (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23: 901-944.
4. Nordahl EA, Rydengard V, Nyberg P, Nitsche DP, Morgelin M, et al. (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101: 16879-16884.
5. Eliasson M, Egesten A (2008) Antibacterial chemokines-actors in both innate and adaptive immunity. Contrib Microbiol 15: 101-117.
6. El Karim IA, Linden GJ, Orr DF, Lundy FT (2008) Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol 200: 11-16.
7. Seebah S, Suresh A, Zhuo S, Choong YH, Chua H, et al. (2007) Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides. Nucleic Acids Res 35: D265-268.
8. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
9. Schultz H, Weiss JP (2007) The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 384: 12-23.
10. Soehnlein O, Lindbom L (2009) Neutrophil-derived azurocidin alarms the immune system. JLeukoc Biol 85: 344-351.
11. Rydengard V, Olsson AK, Mörgelin M, Schmidtchen A (2007) Histidine-rich glycoprotein exerts antibacterial activity. FEBS J 274: 377-389.
12. Pratt CW, Church FC (1992) Heparin binding to protein C inhibitor. J Biol Chem 267: 8789-8794.
13. Suzuki K (2008) The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis. J Thromb Haemost 6: 2017-2026.
14. Baumgärtner P, Geiger M, Zieseniss S, Malleier J, Huntington JA, et al. (2007) Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor. J Cell Biol 179: 793-804.
15. Andersson E, Rydenga° rd V, Sonesson A, Mörgelin M, Björck L, et al. (2004) Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271: 1219-1226.
16. Frick IM, Åkesson P, Herwald H, Mörgelin M, Malmsten M, et al. (2006) The contact system-a novel branch of innate immunity generating antibacterial peptides. Embo J 25: 5569-5578.
17. Bevins CL (2003) Antimicrobial peptides as effector molecules of mammalian host defense. Contrib Microbiol 10: 106-148.
18. Nordahl EA, Rydenga° rd V, Nyberg P, Nitsche DP, Mörgelin M, et al. (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci USA 101: 16879-16884.
19. Sørensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
20. Rydengård V, Olsson AK, Mörgelin M, Schmidtchen A (2007) Histidine-rich glycoprotein exerts antibacterial activity. Febs J 274: 377-389.
21. Pohl J, Pereira HA, Martin NM, Spitznagel JK (1990) Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocytespecific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett 272: 200-204.
22. Li W, Adams TE, Kjellberg M, Stenflo J, Huntington JA (2007) Structure of native protein C inhibitor provides insight into its multiple functions. J Biol Chem 282: 13759-13768.
23. Lundqvist K, Herwald H, Sonesson A, Schmidtchen A (2004) Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa. Thromb Haemost 92: 281-287.
24. Geiger M (2007) Protein C inhibitor, a serpin with functions in- and outside vascular biology. Thromb Haemost 97: 343-347.
25. PrendesMJ, Bielek E, Zechmeister-Machhart M, Vanyek-Zavadil E, Carroll VA, et al. (1999) Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. Blood 94: 1300-1312.
26. Shannon O, Hertzen E, Norrby-Teglund A, Mörgelin M, Sjöbring U, et al. (2007) Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol 65: 1147-1157.
27. Olsen RJ, Musser JM (2009) Molecular Pathogenesis of Necrotizing Fasciitis. Annu Rev Pathol: in press.
28. Nizet V (2006) Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 8: 11-26.
29. Johansson L, Thulin P, Sendi P, Hertzén E, Linder A, et al. (2008) Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun 76: 3399-3404.
30. Schmidtchen A, Frick IM, Andersson E, Tapper H, Björck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46: 157-168.
31. Elisen MG, von dem Borne PA, Bouma BN, Meijers JC (1998) Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma. Blood 91: 1542-1547.
32. Collin M, Olsen A (2000) Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 36: 1306-1318.
33. Elisen MG, Maseland MH, Church FC, Bouma BN, Meijers JC (1996) Role of the A+ helix in heparin binding to protein C inhibitor. Thromb Haemost 75: 760-766.
34. Malmsten M, Davoudi M, Walse B, Rydenga° rd V, Pasupuleti M, et al. (2007) Antimicrobial peptides derived from growth factors. Growth Factors 25: 60-70.
35. Åkesson P, Cooney J, Kishimoto F, Björck L (1990) Protein H-a novel IgG binding bacterial protein. Mol Immunol 27: 523-531.
36. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P (1991) Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 137: 167-173.
37. Bengtson SH, Sandén C, Mörgelin M, Marx PF, Leeb-Lundberg FLM, et al. (2009) Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system. J Innate Immun 1: 18-28.